Literature DB >> 9543155

Detection of CD40 on human thyroid follicular cells: analysis of expression and function.

R A Metcalfe1, R S McIntosh, F Marelli-Berg, G Lombardi, R Lechler, A P Weetman.   

Abstract

Thyroid follicular cells (TFC) are a common target of autoimmune attack, but the role they play in inciting and maintaining this attack is unclear. TFC express cytokines, adhesion molecules, and class I and II major histocompatibility complex molecules, but without additional signals that costimulate T cells, they may down-regulate, rather than stimulate, T cell function. In this report, we have investigated whether TFC can express the CD40 molecule, which plays a crucial role in the reciprocal two-way communication between T and B cells. We have shown by immunohistochemistry and flow cytometry that CD40 is expressed by TFC in vivo and in vitro in both autoimmune and nonautoimmune glands. CD40 expression was up-regulated by interleukin-1alpha and interferon-gamma, but not by TSH. Although there was no significant effect of CD40 ligation on cAMP synthesis or [3H]thymidine incorporation, there was a significant increase in interleukin-6 release by TFC. Thus, although TFC do not express members of the B7 family of T cell costimulators, they do express CD40, indicating the possibility of mutually stimulatory T cell-TFC interaction. This has important implications, both for TFC synthesis of immunological mediators and for the biasing of T cell behavior toward a T helper 2-type phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543155     DOI: 10.1210/jcem.83.4.4732

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.

Authors:  Naoya Inoue; Mikio Watanabe; Hiroya Yamada; Kazuya Takemura; Fumiaki Hayashi; Noriko Yamakawa; Maiko Akahane; Yu Shimizuishi; Yoh Hidaka; Yoshinori Iwatani
Journal:  J Clin Immunol       Date:  2012-06-17       Impact factor: 8.317

Review 2.  Cytokines, Graves' disease, and thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Nicole Khadavi; Terry J Smith
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

3.  Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients.

Authors:  Fengming Wang; Tao Yan; Lujun Chen; Xuemin Chen; Tong Liu; Shuang Shen; Ting Li; Li Gao; Ting Wang; Jing Sun; Cuiping Liu; Haorong Wu; Xueguang Zhang; Lei Chen
Journal:  J Clin Immunol       Date:  2012-06-17       Impact factor: 8.317

4.  Genotype and phenotype predictors of relapse of graves' disease after antithyroid drug withdrawal.

Authors:  Pei-Wen Wang; I-Ya Chen; Suh-Hang Hank Juo; Edward Hsi; Rue-Tsuan Liu; Ching-Jung Hsieh
Journal:  Eur Thyroid J       Date:  2012-10-12

Review 5.  Genetic and epigenetic mechanisms in thyroid autoimmunity.

Authors:  Alia Hasham; Yaron Tomer
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 6.  Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Terry J Smith
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-10       Impact factor: 3.243

7.  Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.

Authors:  R M Ruggeri; D Villari; A Simone; R Scarfi; M Attard; F Orlandi; G Barresi; F Trimarchi; M Trovato; S Benvenga
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

Review 8.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

9.  Agonistic anti-CD40 induces thyrocyte proliferation and promotes thyroid autoimmunity by increasing CD40 expression on thyroid epithelial cells.

Authors:  Timothy Kayes; Yujiang Fang; Shiguang Yu; Edward Downey; Shufang Wang; Helen Braley-Mullen
Journal:  J Immunol       Date:  2013-03-15       Impact factor: 5.422

Review 10.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.